News 23andMe Holding Co.

Equities

ME

US90138Q1085

Market Closed - Nasdaq Other stock markets 04:00:04 2024-04-23 pm EDT			5-day change	1st Jan Change
0.495 ^USD	+7.52%		+26.89%	-45.81%

Apr. 23	Petros, Lemonaid Health Collaborate to Expand Stendra Availability	MT
Apr. 18	Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Petros, Lemonaid Health Collaborate to Expand Stendra Availability	Apr. 23	MT
Health Care Flat on Rotation From Rate-Sensitive Sectors -- Health Care Roundup	Apr. 18	DJ
US Equity Markets Close Mixed Thursday	Apr. 18	MT
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	Apr. 18	MT
Sector Update: Health Care Stocks Ease in Afternoon Trading	Apr. 18	MT
Sector Update: Health Care	Apr. 18	MT
News Highlights : Top Company News of the Day - Thursday at 1 PM ET	Apr. 18	DJ
Top Midday Stories: Taiwan Semiconductor Manufacturing, Blackstone, Elevance Health, D.R. Horton, Infosys and Marsh & McLennan Report Earnings; Tesla's Musk Says Laid-Off Employees Received "Incorrectly Low" Severance; 23andME CEO Mulls Taking Company Private; Northrop Grumman Working with SpaceX on Spy Satellite	Apr. 18	MT
News Highlights : Top Company News of the Day - Thursday at 11 AM ET	Apr. 18	DJ
23andMe CEO Mulls Plan to Take Company Private	Apr. 18	MT
23andMe CEO Mulls Plan to Take Company Private	Apr. 18	MT
23andMe CEO Considering Taking Company Private	Apr. 18	MT
23andMe announces CEO’s intention to pursue a potential take-private	Apr. 18	GL
23andMe announces CEO’s intention to pursue a potential take-private	Apr. 18	AQ
North American Morning Briefing : Stock Futures Rise After TSMC Earnings	Apr. 18	DJ
News Highlights : Top Company News of the Day - Thursday at 5 AM ET	Apr. 18	DJ
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	Apr. 18	DJ
23andMe CEO Wojcicki considering taking firm private, filing shows	Apr. 17	RE
Citigroup Adjusts 23andMe Price Target to $0.47 From $0.85, Maintains Neutral Rating	Apr. 16	MT
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024	Apr. 05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

INTERVIEW - Anne Wojcicki, CEO of 23andMe: partnership with Amazon and cancer treatment results

July 13, 2023 at 02:26 pm EDT